Scientists hunt blood clues to predict which breast cancer patients beat the odds
NCT ID NCT07407244
Summary
This study aims to find biological markers that can predict which early breast cancer patients will respond best to chemotherapy given before surgery. Researchers will analyze tumor tissue and blood samples from 268 patients to look for immune system signals and traces of cancer in the blood. The goal is to help doctors better identify patients most likely to benefit from this type of treatment approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.